Download PDF
1
/
Pages
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Renal safety outcomes of spironolactone in patients with resistant hypertension
Isabel Galceran; Susana Vázquez; Xavier Durán; Sara Outón; Julio Pascual; Anna Oliveras;
Nefrologia (English Version). 2020;40:413-9
Chronic kidney disease progression in patients with resistant hypertension subject to 2 therapeutic strategies: Intensification with loop diuretics vs aldosterone antagonists
U. Verdalles; M. Goicoechea; S. García de Vinuesa; E. Torres; A. Hernández; E. Verde; A. Pérez de José; J. Luño;
Nefrologia (English Version). 2020;40:66-74
Mineralcorticoid receptor blockers in chronic kidney disease
Sara Erraez; Manuel López-Mesa; Pablo Gómez-Fernández;
Nefrologia (English Version). 2021;41:258-75